US Stocks
/
Madrigal Pharmaceuticals, Inc. Share Price
Madrigal Pharmaceuticals, Inc. Share Price

Madrigal Pharmaceuticals, Inc. Share Price

NASDAQ: MDGL | Large Cap
$471.93
-$4.88 (-1.02%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Madrigal Pharmaceuticals, Inc. Stock Performance

Open
$478.21
Prev. Close
$476.81
Circuit Range
N/A
Day Range
$470.95 - $481.26
Year Range
$393.82 - $614.13
Volume
26,227
Average Traded
$475.04

Madrigal Pharmaceuticals, Inc. Share Price Today

As of 10 October 2026, Madrigal Pharmaceuticals, Inc.'s share price is $471.93. The stock opened at $478.21, compared to its previous close of $476.81. During today's trading session, Madrigal Pharmaceuticals, Inc.'s share price traded between $470.95 and $481.26, with an average price of $476.11. Over the past 52 weeks, the stock has recorded a high of $614.13 and a low of $393.82. In terms of performance, Madrigal Pharmaceuticals, Inc.'s share price has declined by 8.64% over the last six months and is up 12.60% on a year-on-year basis.

Madrigal Pharmaceuticals, Inc. Share Price Chart

$470.95$481.26
L
Show Current Price
H

Madrigal Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$10.59B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-14.07
Revenue (TTM)
$958.40B
Return On Equity (TTM)
-62.07%
Profit Margin
-30.08%
Debt to Equity
0.65
Quarterly Earnings Growth YoY
49.26%

Madrigal Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$287.27$321.08$311.34$364.25
Net Profit-$114.19-$58.58-$94.39-$57.94
Net Profit Margin-39.75%-18.24%-30.32%-15.91%
Income ChangeN/A48.70%-61.13%38.62%

Madrigal Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$180.13$958.40
Net Profit-$295.35-$373.63-$465.89-$288.28
Net Profit MarginN/AN/A-258.64%-30.08%
Income ChangeN/A-26.50%-24.69%38.12%

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Madrigal Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$503.21
$471.60
-6.39%
Sep 2026
$544.35
$503.77
-7.30%
Aug 2026
$468.70
$543.45
+16.19%
Jul 2026
$535.50
$467.72
-12.88%
Jun 2026
$494.44
$536.85
+8.03%
May 2026
$514.33
$496.94
-3.79%
Apr 2026
$544.66
$516.53
-1.27%
Mar 2026
$429.31
$523.17
+21.08%
Feb 2026
$486.09
$432.09
-11.58%
Jan 2026
$582.02
$488.67
-16.10%
Dec 2025
$591.94
$582.42
-2.46%
Nov 2025
$420.95
$597.12
+42.47%

MDGL Share Price FAQs

What is Madrigal Pharmaceuticals, Inc. share price today?

chevron-up
Madrigal Pharmaceuticals, Inc. share price today is $471.93 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Madrigal Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Madrigal Pharmaceuticals, Inc. stock is $614.13, while the 52 week low is $393.82 as of 10 Oct '26.

What is MDGL's market capitalisation today?

chevron-up
MDGL market capitalisation is $10.59B as of October 10, 2026, at 4:41 am IST.

What is MDGL's net income for the last quarter?

chevron-up
MDGL's net income for the last quarter is -57.94B USD.

What is the 5 year returns of MDGL?

chevron-up
The 5 year returns of MDGL is 506.98% as on 10 Oct '26.

What is the high & low stock price of MDGL today?

chevron-up
MDGL stock price hit a high of $481.26 and low of $470.95 as of 10 Oct '26.

Can I buy MDGL shares in India?

chevron-up
Yes. You can buy MDGL in India by opening an international trading account.